在肝细胞癌中跨越免疫逃避和血管动力学的新疗法边界

Sulin Wu1, Namrata Anand1, Zhoubo Guo1

  • 1Section of Hematology and Oncology, Department of Internal Medicine, University of Chicago, 900 E. 57th St., KCBD 7114, Chicago, IL 60637, USA.

Cancers
|June 13, 2025
PubMed
概括

肝细胞癌 (HCC) 治疗正在通过向瘤微环境 (TME) 转向精密瘤学. 新的策略侧重于结合疗法以克服耐药性并改善这种致命的肝癌的治疗结果.